Halozyme Therapeutics shares owned by Congress Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Congress Asset Management
from 13F filings
Historical chart of Congress Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Congress Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $17M | 408k | 40.68 |
| 2023-12-31 | $13M | 351k | 36.96 |
| 2023-09-30 | $12M | 304k | 38.20 |
| 2023-06-30 | $10M | 289k | 36.07 |